Matthias Zander
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Matthias Zander has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Christian Ulrichs
Division Urban Plant Ecophysiology, Albrecht Daniel Thaer-Institute of Agricultural and Horticultural Sciences, Humboldt-Universität zu Berlin, Lentzeallee 55/57, 14195 Berlin, Germany
3 shared publications - Nadja Förster
Division Urban Plant Ecophysiology, Albrecht Daniel Thaer-Institute of Agricultural and Horticultural Sciences, Humboldt-Universität zu Berlin, Lentzeallee 55/57, 14195 Berlin, Germany
3 shared publications - Angela Köhler
Humboldt-Universität zu Berlin, Faculty of Life Sciences, Division Urban Plant Ecophysiology, Lentzeallee 55/57, Berlin 14195, Germany
2 shared publications - Corinna Dawid
Chair of Food Chemistry and Molecular Sensory Science, TUM School of Life Sciences, Technical University of Munich, Freising, Germany
1 shared publication - Corinna Herz
Molecular Preventive Medicine, University Medical Center and Faculty of Medicine, University of Freiburg, Engesserstrasse 4, D-79108 Freiburg, Germany
1 shared publication - Evelyn Lamy
Molecular Preventive Medicine, University Medical Center and Faculty of Medicine, University of Freiburg, Engesserstrasse 4, D-79108 Freiburg, Germany
1 shared publication
Latest Publications
- 28 August 2023
- Published by Elsevier in Fitoterapia
- Vol. 170, 105660
Inter- and intraspecific diversity of Salix bark phenolic profiles – A resource for the pharmaceutical industry
- 28 August 2023
- Published by Elsevier in Fitoterapia
- Vol. 170, 105660
Inter- and intraspecific diversity of Salix bark phenolic profiles – A resource for the pharmaceutical industry
- Open Access
- 15 October 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (20) , 11138
Identification of Salicylates in Willow Bark (Salix Cortex) for Targeting Peripheral Inflammation
Salix cortex-containing medicine is used against pain conditions, fever, headaches, and inflammation, which are partly mediated via arachidonic acid-derived prostaglandins (PGs). We used an activity-guided fractionation strategy, followed by structure elucidation experiments using LC-MS/MS, CD-spectroscopy, and 1D/2D NMR techniques, to identify the compounds relevant for the inhibition of PGE2 release from activated human peripheral blood mononuclear cells. Subsequent compound purification by means of preparative and semipreparative HPLC revealed 2-O-acetylsalicortin (1), 3-O-acetylsalicortin (2), 2-O-acetylsalicin (3), 2,6-O-diacetylsalicortin (4), lasiandrin (5), tremulacin (6), and cinnamrutinose A (7). In contrast to 3 and 7, compounds 1, 2, 4, 5, and 6 showed inhibitory activity against PGE2 release with different potencies. Polyphenols were not relevant for the bioactivity of the Salix extract but salicylates, which degrade to, e.g., catechol, salicylic acid, salicin, and/or 1-hydroxy-6-oxo-2-cycohexenecarboxylate. Inflammation presents an important therapeutic target for pharmacological interventions; thus, the identification of relevant key drugs in Salix could provide new prospects for the improvement and standardization of existing clinical medicine.- 15 October 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (20) , 11138
Open AccessIdentification of Salicylates in Willow Bark (Salix Cortex) for Targeting Peripheral Inflammation
Salix cortex-containing medicine is used against pain conditions, fever, headaches, and inflammation, which are partly mediated via arachidonic acid-derived prostaglandins (PGs). We used an activity-guided fractionation strategy, followed by structure elucidation experiments using LC-MS/MS, CD-spectroscopy, and 1D/2D NMR techniques, to identify the compounds relevant for the inhibition of PGE2 release from activated human peripheral blood mononuclear cells. Subsequent compound purification by means of preparative and semipreparative HPLC revealed 2-O-acetylsalicortin (1), 3-O-acetylsalicortin (2), 2-O-acetylsalicin (3), 2,6-O-diacetylsalicortin (4), lasiandrin (5), tremulacin (6), and cinnamrutinose A (7). In contrast to 3 and 7, compounds 1, 2, 4, 5, and 6 showed inhibitory activity against PGE2 release with different potencies. Polyphenols were not relevant for the bioactivity of the Salix extract but salicylates, which degrade to, e.g., catechol, salicylic acid, salicin, and/or 1-hydroxy-6-oxo-2-cycohexenecarboxylate. Inflammation presents an important therapeutic target for pharmacological interventions; thus, the identification of relevant key drugs in Salix could provide new prospects for the improvement and standardization of existing clinical medicine. - 1 October 2020
- Published by Elsevier in Plant Physiology and Biochemistry
- Vol. 155, 311-320
Compound-specific responses of phenolic metabolites in the bark of drought-stressed Salix daphnoides and Salix purpurea
- 1 October 2020
- Published by Elsevier in Plant Physiology and Biochemistry
- Vol. 155, 311-320
Compound-specific responses of phenolic metabolites in the bark of drought-stressed Salix daphnoides and Salix purpurea